Floatz logo

Cipralex

Anxiety Disorders

Tianjin Medical University General HospitalPhase 4 / ApprovedDormant
A
81/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
71/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Anxiety Disorders cohort.

Asset / SponsorPhaseRating
Sertraline
Holland Bloorview Kids Rehabilitation Hospital
Phase 4BBB
Olanzapine
Tianjin Medical University General Hospital
Phase 4BBB
CITALOPRAM
Tianjin Medical University General Hospital
Phase 4BBB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Theresa Jacob, PhD, MPH
Phase 4BBB
Vortioxetine
H. Lundbeck A/S
Phase 4BB

View all 50 →

Same molecule, other indications

Cipralex is also rated in:

bipolar I disorderDormant
BBB
Indicative ·
77 / 100
View asset →
dysthymic disorderDormant
BBB
Indicative ·
76 / 100
View asset →
depressive disorderDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →